Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Cai XT"'
Publikováno v:
International Journal of General Medicine, Vol Volume 14, Pp 7729-7740 (2021)
Xin-Tian Cai,1,2,* Qing Zhu,1,2,* Sha-Sha Liu,2 Meng-Ru Wang,2 Ting Wu,2 Jing Hong,2 Jun-Li Hu,2 Nanfang Li1,2 1Graduate School, Xinjiang Medical University, Urumqi, Xinjiang, People’s Republic of China; 2Hypertension Center of People’s H
Externí odkaz:
https://doaj.org/article/b7ad0880605743639c9598eabb40fcb2
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity, Vol Volume 14, Pp 2087-2101 (2021)
Xin-Tian Cai,1 Li-Wei Ji,2 Sha-Sha Liu,1 Meng-Ru Wang,1 Mulalibieke Heizhati,1 Nan-Fang Li1 1Hypertension Center of People’s Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, National Health Committee Key Laboratory of
Externí odkaz:
https://doaj.org/article/5092b2a8f0cc4c49bff826074adb1fd4
Dihydroartemisinin overcomes the resistance to osimertinib in EGFR-mutant non-small-cell lung cancer
Publikováno v:
Pharmacological Research
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Osimertinib, a third-generation EGFR tyrosine kinase inhibitor (TKI), is commonly used to treat EGFR-mutant non-small-cell lung cancer (NSCLC). However, acquired resistance to mutant EGFR (T790M) can evolve following osimertinib treatment. High react
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::5b3b357c744f937fca493bb64d3a8871
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1957
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1957
Autor:
Wang, JQ, Zhu, YH, Chen, J, Yang, YH, Zhu, LX, Zhao, JY, Yang, Y, Cai, XT, Hu, CP, Rosell, R, Sun, XY, Cao, P
Publikováno v:
Acta Pharmaceutica Sinica B
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Pancreatic cancer is one of the most aggressive cancers with poor prognosis and a low 5-year survival rate. The family of P21-activated kinases (PAKs) appears to modulate many signaling pathways that contribute to pancreatic carcinogenesis. In this w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::a1a1c7031f4533d0473a4e6bf7215e9f
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4112
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4112
Autor:
Rosell, R, Chaib, I, Karachaliou, N, Cao, P, Vila, MAM, Cai, XT, Drozdowskyj, A, Yang, J, Hu, CP, Cardona, A, Frias, A, Lazzari, C, Verlicchi, A, Servat, JC, Servat, CC, Serrano, JLR, Vergnenegre, A, Ma, P, Bivona, T
Publikováno v:
Journal of Thoracic Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::ab99af876aa1a4b08c8fbbffe59e46bc
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6135
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6135
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rong ZX; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, Guangdong, China., Wei W; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, Guangdong, China.; Department of Oncology, Xiangyang Central Hospital, Hubei University of Arts and Science, Xiangyang, 441000, Hubei, China., Zeng Q; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, Guangdong, China., Cai XT; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, Guangdong, China., Wang YY; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China., Wang J; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, Guangdong, China., Luo HS; Department of Radiation Oncology, Shantou Central Hospital, Shantou, 515031, Guangdong, China., Xiao LS; Information Management and Big Data Center, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.; Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Hepatology Unit and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China., Lin JR; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, Guangdong, China., Bai X; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, Guangdong, China., Zhang YP; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, Guangdong, China.; Information Management and Big Data Center, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China., Han DD; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, Guangdong, China., Dong ZY; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, Guangdong, China., Wang W; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, Guangdong, China. wwei9500@smu.edu.cn., Wu DH; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, Guangdong, China. 18602062748@163.com., Ma SC; Department of Thoracic Surgery, The First Affiliated Hospital, Sun Yat-Sen University, 58 Zhongshan 2nd Road, Guangzhou, 510080, Guangdong, China. masc@mail.sysu.edu.cn.
Publikováno v:
BMC medicine [BMC Med] 2024 Oct 08; Vol. 22 (1), pp. 443. Date of Electronic Publication: 2024 Oct 08.
Autor:
Cai XT; Immunology Discovery and Regenerative Medicine, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Jia M; Department of Computational and Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA; Joint Carnegie Mellon University-University of Pittsburgh Ph.D. Program in Computational Biology, Pittsburgh, PA 15213, USA., Heigl T; Immunology Discovery and Regenerative Medicine, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Shamir ER; Department of Research Pathology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Wong AK; Immunology and Infectious Diseases, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Hall BM; Immunology and Infectious Diseases, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Arlantico A; Immunology and Infectious Diseases, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Hung J; Department of Research Pathology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Menon HG; Department of Next Generation Sequencing and Microchemistry, Proteomics, and Lipidomics, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Darmanis S; Department of Next Generation Sequencing and Microchemistry, Proteomics, and Lipidomics, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Brightbill HD; Immunology and Infectious Diseases, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Garfield DA; Immunology Discovery and Regenerative Medicine, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA; Bioinformatics, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Rock JR; Immunology Discovery and Regenerative Medicine, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA. Electronic address: rockj3@gene.com.
Publikováno v:
Cell reports [Cell Rep] 2024 Aug 27; Vol. 43 (8), pp. 114569. Date of Electronic Publication: 2024 Jul 31.